| 英文名稱 | Anlotinib Dihydrochloride (AL3818 Dihydrochloride); Anlotinib 2HCl |
|---|---|
| 中文名稱 | 鹽酸安羅替尼; 安羅替尼鹽酸鹽 |
| CAS號(hào) | 1360460-82-7 |
| 分子式 | C23H24Cl2FN3O3 |
| 分子量 | 480.36 |
| 外觀 | Light yellow to yellow powder |
| 英文名稱 | Anlotinib Dihydrochloride (AL3818 Dihydrochloride); Anlotinib 2HCl |
|---|---|
| 中文名稱 | 鹽酸安羅替尼; 安羅替尼鹽酸鹽 |
| CAS號(hào) | 1360460-82-7 |
| 分子式 | C23H24Cl2FN3O3 |
| 分子量 | 480.36 |
| 外觀 | Light yellow to yellow powder |
Anlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.